Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
SODIUM CHLORIDE
Fresenius Kabi Limited
B05XA03
SODIUM CHLORIDE
0.9 %v/w
Solvent for Parenteral Use
Product subject to prescription which may not be renewed (A)
sodium chloride
Marketed
2009-08-28
Package leafl et: Information for the user SODIUM CHLORIDE 0.9% W/V SOLVENT FOR PARENTERAL USE Sodium chloride Read all of this leafl et carefully before you start using this medicine because it contains important information for you. - Keep this leafl et. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leafl et. See section 4. What is in this leafl et: 1. What Sodium Chloride is and what it is used for 2. What you need to know before you use Sodium Chloride 3. How to use Sodium Chloride 4. Possible side effects 5. How to store Sodium Chloride 6. Contents of the pack and other information 1. What Sodium Chloride is and what it is used for Sodium Chloride is indicated as a solvent of medicines that should be administered intravenously, intramuscularly or subcutaneously as a support of the addition of medicines. 2. What you need to know before you use Sodium Chloride Do not use Sodium Chloride - If you have had some allergic or unusual reaction to sodium chloride. - If you have a high concentration of sodium in your blood (hypernatremia) - If you have an increase of muscle tone (hypertonia) - If you suffer from cardiac insuffi ciency (incapability of the heart to pump the necessary amount of blood) - If you have some heart, liver or kidney disorder and if you suffer from an accumulation of water (oedema) in your body - If you have a severe high blood pressure (severe hypertension) - If you have an excess of acidity in your blood (metabolic acidosis) Warnings and precautions Talk to your doctor or nurse before using Sodium Chloride. - Once opened the solutions should be used immediately. - In case of subcutaneous administration do not add any supplement, since isotonia would change. - Do n Prečítajte si celý dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sodium chloride 0.9% w/v solvent for parenteral use 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Composition per 100 ml: Electrolytes mmol/l mEq/l Sodium chloride 0.9 g Na + 154 154 Water for injections q.s.p. 100 ml Cl - 154 154 Each ml of solution contains 9 mg of sodium chloride Osmolarity: 308 mOsmol/L. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solvent for parenteral use. Clear and colourless solution, free or practically free from particles. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Vehicle or diluent for parenteral administration of medicines for intravenous, intramuscular or subcutaneous route. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The amount to be used will depend on the concentration wanted for the administration of the medicine to be dissolved. Method of administration Intravenous, intramuscular or subcutaneous use. 4.3 CONTRAINDICATIONS Due to the indications of the product, contraindications depend on the medicine to be dissolved. In general, the administration of this product is contraindicated in the following situations: Hypernatremia Hypertonia Cardiac insufficiency Oedematous states in patients with cardiac, hepatic or renal disorders Severe hypertension Metabolic acidosis 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _3_ _1_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _2_ _1_ _7_ _7_ _1_ _3_ _8_ _p_ Prečítajte si celý dokument